Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal MR, François A, Altinay S, Arnould L, Balkenhol M, Broeckx G, Burguès O, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Hastir D, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchiò C, Martin Martinez MD, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban A, Sinke R, Stanciu-Pop CM, van Deurzen CHM, Van de Vijver KK, Van Rompuy AS, Vincent-Salomon A, Wen HY, Wong S, Bouzin C, Galant C. Van Bockstal MR, et al. Among authors: wen hy. Mod Pathol. 2021 Dec;34(12):2130-2140. doi: 10.1038/s41379-021-00865-z. Epub 2021 Jul 3. Mod Pathol. 2021. PMID: 34218258 Free PMC article.
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology.
Weisman PS, Ng CK, Brogi E, Eisenberg RE, Won HH, Piscuoglio S, De Filippo MR, Ioris R, Akram M, Norton L, Weigelt B, Berger MF, Reis-Filho JS, Wen HY. Weisman PS, et al. Among authors: wen hy. Mod Pathol. 2016 May;29(5):476-88. doi: 10.1038/modpathol.2016.39. Epub 2016 Mar 4. Mod Pathol. 2016. PMID: 26939876 Free PMC article.
Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
Tozbikian G, Brogi E, Vallejo CE, Giri D, Murray M, Catalano J, Olcese C, Van Zee KJ, Wen HY. Tozbikian G, et al. Among authors: wen hy. Int J Surg Pathol. 2017 Apr;25(2):100-107. doi: 10.1177/1066896916662154. Epub 2016 Aug 4. Int J Surg Pathol. 2017. PMID: 27481892 Free PMC article.
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Geyer FC, Berman SH, Marchiò C, Burke KA, Guerini-Rocco E, Piscuoglio S, Ng CK, Pareja F, Wen HY, Hodi Z, Schnitt SJ, Rakha EA, Ellis IO, Norton L, Weigelt B, Reis-Filho JS. Geyer FC, et al. Among authors: wen hy. Mod Pathol. 2017 Jan;30(1):69-84. doi: 10.1038/modpathol.2016.161. Epub 2016 Oct 7. Mod Pathol. 2017. PMID: 27713419 Free PMC article.
Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study.
Li W, Han Y, Wang C, Guo X, Shen B, Liu F, Jiang C, Li Y, Yang Y, Lang R, Fan Y, Gu F, Niu Y, Zhang X, Zhang L, Wen HY, Fu L. Li W, et al. Among authors: wen hy. Mod Pathol. 2018 Jun;31(6):956-964. doi: 10.1038/s41379-018-0024-8. Epub 2018 Feb 5. Mod Pathol. 2018. PMID: 29403084 Free article.
The Genomic Landscape of Mucinous Breast Cancer.
Pareja F, Lee JY, Brown DN, Piscuoglio S, Gularte-Mérida R, Selenica P, Da Cruz Paula A, Arunachalam S, Kumar R, Geyer FC, Silveira C, da Silva EM, Li A, Marchiò C, Ng CKY, Mariani O, Fuhrmann L, Wen HY, Norton L, Vincent-Salomon A, Brogi E, Reis-Filho JS, Weigelt B. Pareja F, et al. Among authors: wen hy. J Natl Cancer Inst. 2019 Jul 1;111(7):737-741. doi: 10.1093/jnci/djy216. J Natl Cancer Inst. 2019. PMID: 30649385 Free PMC article.
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Dano H, Altinay S, Arnould L, Bletard N, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchió C, Martinez DM, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban AM, Sinke R, Stanciu-Pop CM, Stobbe C, van Deurzen CHM, Van de Vijver K, Van Rompuy AS, Verschuere S, Vincent-Salomon A, Wen H, Bouzin C, Galant C, Van Bockstal MR. Dano H, et al. Mod Pathol. 2020 Mar;33(3):354-366. doi: 10.1038/s41379-019-0367-9. Epub 2019 Sep 18. Mod Pathol. 2020. PMID: 31534203 Free PMC article.
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.
Reisenbichler ES, Han G, Bellizzi A, Bossuyt V, Brock J, Cole K, Fadare O, Hameed O, Hanley K, Harrison BT, Kuba MG, Ly A, Miller D, Podoll M, Roden AC, Singh K, Sanders MA, Wei S, Wen H, Pelekanou V, Yaghoobi V, Ahmed F, Pusztai L, Rimm DL. Reisenbichler ES, et al. Mod Pathol. 2020 Sep;33(9):1746-1752. doi: 10.1038/s41379-020-0544-x. Epub 2020 Apr 16. Mod Pathol. 2020. PMID: 32300181 Free PMC article.
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
Hoda RS, Brogi E, Dos Anjos CH, Grabenstetter A, Ventura K, Patil S, Selenica P, Weigelt B, Reis-Filho JS, Traina T, Robson M, Norton L, Wen HY. Hoda RS, et al. Among authors: wen hy. Mod Pathol. 2020 Nov;33(11):2221-2232. doi: 10.1038/s41379-020-0606-0. Epub 2020 Jul 1. Mod Pathol. 2020. PMID: 32612248 Free PMC article.
213 results